70720-022 : Margenza 25 mg/ml Intravenous Injection, Solution, Concentrate


NDC: 70720-022
Labeler: Tersera Therapeutics LLC
Product Type: Human Prescription Drug
Drug Name:  Margenza
Dosage Form: Intravenous Injection, Solution, Concentrate
Application #: BLA761150
Rev. Date: 


Active Ingredients:

  • Margetuximab

Dosage Strength:

  • 25 mg/mL

Pharmaceutical Classes:

  • HER2/Neu/cerbB2 Antagonists [MoA]
  • HER2/neu Receptor Antagonist [EPC]

Related Products:

Based on records with the same trade name.
  • 74527-022 Margenza 25 mg/ml Intravenous Injection, Solution, Concentrate by Macrogenics, Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70720-022 QR Code

< Prev: 70719-0003Next: 70720-100 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.